Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Bruker (BRKR)

Bruker realigns reporting segments into four; consolidated results unchanged

Neutral Impact 2 of 5 other

Effective July 1, 2026, Bruker reorganized its reportable segments, with BSI BIOS, BSI BMID, BSI NANO and BEST now reported. The company furnished recast segment data for 2024, 2025 and 2026 periods so investors can compare on the new basis. The filing states the change has no effect on historical consolidated results of operations, financial position or cash flows, and is not a restatement.

Key points

  • Reorganization effective July 1, 2026 creates four reportable segments: BSI BIOS, BSI BMID, BSI NANO and BEST.
  • Exhibit 99.1 provides recast segment data for fiscal 2025 and 2024, quarterly 2025 and 2026 periods, and the nine months ended September 30, 2025.
  • Fiscal 2025 revenue from external customers is $3.4 billion on both the as-reported and recast bases, per the exhibit.

The filing

CompanyBruker (BRKR)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:07 PM ET
Accession number0001193125-26-449782

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:18 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.